相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Passenger Mutations in More Than 2,500 Cancer Genomes: Overall Molecular Functional Impact and Consequences
Sushant Kumar et al.
CELL (2020)
Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction Networks
Helen Zhu et al.
MOLECULAR CELL (2020)
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
Esther Rheinbay et al.
NATURE (2020)
Pan-cancer analysis of whole genomes
Peter J. Campbell et al.
NATURE (2020)
The repertoire of mutational signatures in human cancer
Ludmil B. Alexandrov et al.
NATURE (2020)
Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma
Md Gulam Musawwir Khan et al.
BMC CANCER (2020)
Identification of Cancer Drivers at CTCF Insulators in 1,962 Whole Genomes
Eric Minwei Liu et al.
CELL SYSTEMS (2019)
COSMIC: the Catalogue Of Somatic Mutations In Cancer
John G. Tate et al.
NUCLEIC ACIDS RESEARCH (2019)
DNA Replication and associated repair pathways are involved in the mutagenesis of methylated cytosine
Marketa Tomkova et al.
DNA REPAIR (2018)
MutationalPatterns: comprehensive genome-wide analysis of mutational processes
Francis Blokzijl et al.
GENOME MEDICINE (2018)
Recurrent and functional regulatory mutations in breast cancer
Esther Rheinbay et al.
NATURE (2017)
Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma
Michael E. Feigin et al.
NATURE GENETICS (2017)
Impact of cytosine methylation on DNA binding specificities of human transcription factors
Yimeng Yin et al.
SCIENCE (2017)
TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT
Richard Hill et al.
NATURE COMMUNICATIONS (2017)
Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis
Eric Letouze et al.
NATURE COMMUNICATIONS (2017)
Discovery of Cancer Driver Long Noncoding RNAs across 1112 Tumour Genomes: New Candidates and Distinguishing Features
Andres Lanzos et al.
Scientific Reports (2017)
Expression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer
Martin Chevrier et al.
BMC CANCER (2017)
De novo identification of replication-timing domains in the human genome by deep learning
Feng Liu et al.
BIOINFORMATICS (2016)
JASPAR 2016: a major expansion and update of the open-access database of transcription factor binding profiles
Anthony Mathelier et al.
NUCLEIC ACIDS RESEARCH (2016)
Negative selection maintains transcription factor binding motifs in human cancer
Ilya E. Vorontsov et al.
BMC GENOMICS (2016)
Direct Identification of Hundreds of Expression-Modulating Variants using a Multiplexed Reporter Assay
Ryan Tewhey et al.
CELL (2016)
SOCS1 in cancer: An oncogene and a tumor suppressor
Claudia Beaurivage et al.
CYTOKINE (2016)
A Significant Regulatory Mutation Burden at a High-Affinity Position of the CTCF Motif in Gastrointestinal Cancers
Husen M. Umer et al.
HUMAN MUTATION (2016)
Nucleotide excision repair is impaired by binding of transcription factors to DNA
Radhakrishnan Sabarinathan et al.
NATURE (2016)
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Serena Nik-Zainal et al.
NATURE (2016)
Genome-scale high-resolution mapping of activating and repressive nucleotides in regulatory regions
Jason Ernst et al.
NATURE BIOTECHNOLOGY (2016)
Maps of context-dependent putative regulatory regions and genomic signal interactions
Klev Diamanti et al.
NUCLEIC ACIDS RESEARCH (2016)
Increased Oxidative Stress in the Proximal Stomach of Patients with Barrett's Esophagus and Adenocarcinoma of the Esophagus and Esophagogastric Junction
Juha Kauppi et al.
TRANSLATIONAL ONCOLOGY (2016)
OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations
Loris Mularoni et al.
GENOME BIOLOGY (2016)
Accelerated apoptosis of peripheral blood monocytes in Cebpb-deficient mice
Akihiro Tamura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
C/EBPβ (CEBPB) protein binding to the C/EBP|CRE DNA 8-mer TTGC|GTCA is inhibited by 5hmC and enhanced by 5mC, 5fC, and 5caC in the CG dinucleotide
Syed Khund Sayeed et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
The Genotype-Tissue Expression (GTEx) Project
Latarsha J. Carithers et al.
BIOPRESERVATION AND BIOBANKING (2015)
Integrative analysis of 111 reference human epigenomes
Anshul Kundaje et al.
NATURE (2015)
Recurrent somatic mutations in regulatory regions of human cancer genomes
Collin Melton et al.
NATURE GENETICS (2015)
CTCF/cohesin-binding sites are frequently mutated in cancer
Riku Katainen et al.
NATURE GENETICS (2015)
LARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotations
Lucas Lochovsky et al.
NUCLEIC ACIDS RESEARCH (2015)
CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cells
D. J. Barakat et al.
ONCOGENE (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
The Genotype-Tissue Expression (GTEx) Project
Latarsha J. Carithers et al.
BIOPRESERVATION AND BIOBANKING (2015)
An atlas of active enhancers across human cell types and tissues
Robin Andersson et al.
NATURE (2014)
A promoter-level mammalian expression atlas
Alistair R. R. Forrest et al.
NATURE (2014)
Discovery and saturation analysis of cancer genes across 21 tumour types
Michael S. Lawrence et al.
NATURE (2014)
Genome-wide analysis of noncoding regulatory mutations in cancer
Nils Weinhold et al.
NATURE GENETICS (2014)
Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types
Nils J. Fredriksson et al.
NATURE GENETICS (2014)
Data, information, knowledge and principle: back to metabolism in KEGG
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2014)
An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element
Marc R. Mansour et al.
SCIENCE (2014)
C/EBPβ expression is an independent predictor of overall survival in breast cancer patients by MHCII/CD4-dependent mechanism of metastasis formation
E. Kurzejamska et al.
ONCOGENESIS (2014)
FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer
Yao Fu et al.
GENOME BIOLOGY (2014)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Franklin W. Huang et al.
SCIENCE (2013)
Negative effects of GM-CSF signaling in a murine model of t(8;21)-induced leukemia
Shinobu Matsuura et al.
BLOOD (2012)
GENCODE: The reference human genome annotation for The ENCODE Project
Jennifer Harrow et al.
GENOME RESEARCH (2012)
An integrated encyclopedia of DNA elements in the human genome
Ian Dunham et al.
NATURE (2012)
Role of early growth response 1 in arteriogenesis: Impact on vascular cell proliferation and leukocyte recruitment in vivo
Judith-Irina Pagel et al.
THROMBOSIS AND HAEMOSTASIS (2012)
FIMO: scanning for occurrences of a given motif
Charles E. Grant et al.
BIOINFORMATICS (2011)
CpG methylation of half-CRE sequences creates C/EBPα binding sites that activate some tissue-specific genes
Vikas Rishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
EGR-1 is Regulated by N-Methyl-D-Aspartate-Receptor Stimulation and Associated with Patient Survival in Human High Grade Astrocytomas
Michel Mittelbronn et al.
BRAIN PATHOLOGY (2009)
The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation
Guido Hansen et al.
CELL (2008)
Functional validation of the analplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes
Roberto Piva et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Conditional ablation of C/EBPβ demonstrates its keratinocyte-specific requirement for cell survival and mouse skin tumorigenesis
E Sterneck et al.
ONCOGENE (2006)
The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectin
V Baron et al.
CANCER GENE THERAPY (2006)
A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein β and NF-κB activity in Hodgkin and anaplastic large cell lymphomas
F Jundt et al.
BLOOD (2005)
Epigenetic alteration of the SOCS1 gene in chronic myeloid leukaemia
TC Liu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
CCAAT/enhancer binding protein-β is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling
SY Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
C/EBPβ phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival
M Buck et al.
MOLECULAR CELL (2001)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
